Skip to content

Arcus Biosciences RCUS Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin-156.3%-28.4pp-127.9%+163pp-290.6%-40.6pp-250%-264pp
Net margin-142.9%-33.2pp-109.7%+153pp-262.4%-24.0pp-238.4%-252pp
Returns
Return on equity-63.3%-3.5pp-59.8%-4.9pp-54.9%-19.2pp-35.6%-43.5pp
Return on invested capital-70.1%-0.6pp-69.5%-3.6pp-65.8%-25.4pp-40.4%-49.5pp
Efficiency
Asset turnover0.2×0.0×0.2×+0.1×0.1×0.0×0.1×-0.2×
Liquidity
Current ratio4.4×-0.1×4.5×0.0×4.5×-1.0×5.5×-2.1×
Leverage
Debt-to-equity0.3×0.0×0.3×+0.1×0.3×+0.1×0.2×+0.1×
Per Share
Book value per share$5.88+9.1%$5.38-13.8%$6.24-31.6%$9.13-19.8%
Valuation
Market capitalization$2.95B+116%$1.36B-4.9%$1.43B-4.3%$1.5B-47.3%
Price / sales11.9×+6.7×5.3×-7.0×12.2×-1.1×13.4×+5.9×
Price / book4.7×+1.9×2.8×-0.3×3.1×+0.8×2.3×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Arcus Biosciences's ratios come from?
Every ratio is computed from Arcus Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.